Trials / Unknown
UnknownNCT05580952
Clinical Trial in China
Efficacy and Safety of the J-Valve Transcatheter Aortic Valve Replacement System in Patients With Aortic Regurgitation Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Genesis Medtech Corporation · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to evaluate the effectiveness and safety of the transcatheter aortic valve system in the treatment of patients with severe aortic regurgitation disease who are at high or prohibitive surgical risk.
Detailed description
This study is a prospective, multicenter, single-arm, clinical study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcatheter aortic valve replacement | Transcatheter aortic valve replacement system |
Timeline
- Start date
- 2022-10-14
- Primary completion
- 2023-05-01
- Completion
- 2024-05-01
- First posted
- 2022-10-14
- Last updated
- 2022-10-14
Locations
15 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05580952. Inclusion in this directory is not an endorsement.